Sabaa International is a small Egyptian pharmaceutical and chemical maker that swung from a heavy loss to a solid profit in 2025 — then posted a near-total profit collapse in the first half of 2026. The story is less about scale than about how sharply results can turn in a thinly traded, lightly covered company. Full nameSabaa International Company for Pharmaceutical and Chemical Industries Ticker / exchangeSIPC / Egyptian Exchange (EGX) HeadquartersNot published: not confirmed in available primary sources SectorPharmaceuticals and chemicals EmployeesNot published: not confirmed in available primary sources …
Sabaa International Company for Pharmaceutical and Chemical
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times